运动康复对心力衰竭患者运动能力和生活质量的影响:个体参与者荟萃分析
该个体参与者数据荟萃分析纳入13项随机试验共3990例心衰患者(97%为射血分数降低),评估运动康复对健康相关生活质量和运动能力的影响。12个月随访时,运动康复组6分钟步行试验平均改善21.0米(95%CI 1.57-40.4,P=0.034),明尼苏达心衰生活质量评分平均改善5.9分(95%CI 1.0-10.9,P=0.018)。未发现患者亚组间存在一致的干预效果差异,支持当前国际指南对所有心衰患者推荐运动康复的I类建议。
要点
- 运动康复可显著改善心衰患者12个月时的运动能力(6分钟步行距离平均增加21.0米)。
- 运动康复可显著改善心衰患者12个月时的健康相关生活质量(明尼苏达评分平均改善5.9分)。
- 各患者亚组间未发现一致的干预效果差异,支持对所有心衰患者推荐运动康复。
核心结论
- 基于随机试验的个体参与者数据荟萃分析证实,运动康复可改善心衰患者的健康相关生活质量和运动能力,支持当前国际指南对所有心衰患者提供运动康复的I类推荐。
研究设计与样本
- 个体参与者数据荟萃分析,纳入13项随机试验共3990例心衰患者,运动康复疗程≥3周,随访≥6个月,对照为无运动对照组。
主要发现
- 12个月随访时,运动康复组6分钟步行试验较对照组平均改善21.0米(95%CI 1.57-40.4米,P=0.034)。
- 12个月随访时,运动康复组明尼苏达心衰生活质量评分较对照组平均改善5.9分(95%CI 1.0-10.9,P=0.018)。
- 未发现运动康复效果在年龄、性别、种族、NYHA功能分级、缺血性病因、射血分数和运动能力等亚组间存在一致的差异。
临床怎么用
- 应将运动康复作为心衰患者(尤其是射血分数降低者)的综合管理组成部分,以改善运动能力和生活质量。
- 当前证据支持国际指南对所有心衰患者提供运动康复的I类推荐。
局限性
- 纳入患者以射血分数降低心衰为主(97%),结果对射血分数保留心衰的适用性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous systematic reviews have indicated that exercise-based cardiac rehabilitation (ExCR) for patients with heart failure (HF) has a beneficial effect on health-related quality-of-life (HRQoL) and exercise capacity. However, there is uncertainty regarding potential differential effects of ExCR across HF patient subgroups. OBJECTIVES: The authors sought to undertake an individual participant data (IPD) meta-analysis to: 1) assess the impact of ExCR on HRQoL and exercise capacity in patients with HF; and 2) investigate differential effects of ExCR according to a range of patient characteristics: age, sex, ethnicity, New York Heart Association functional class, ischemic etiology, ejection fraction, and exercise capacity. METHODS: A single dataset was produced, comprising randomized trials where ExCR (delivered for 3 weeks or more) was compared with a no exercise control group. Each trial provided IPD on HRQoL or exercise capacity (or both), with follow-up of 6 months or more. One- and 2-stage meta-analysis models were used to investigate the effect of ExCR overall and the interactions between ExCR and participant characteristics. RESULTS: IPD was obtained from 13 trials for 3,990 patients, predominantly (97%) with reduced ejection fraction HF. Compared with the control group, there was a statistically significant difference in favor of ExCR for HRQoL and exercise capacity. At 12-month follow-up, improvements were seen in 6-min walk test (mean 21.0 m; 95% confidence interval: 1.57 to 40.4 m; p = 0.034) and Minnesota Living With HF score (mean improvement 5.9; 95% confidence interval: 1.0 to 10.9; p = 0.018). No consistent evidence was found of differential intervention effects across patient subgroups. CONCLUSIONS: These results, based on an IPD meta-analysis of randomized trials, confirm the benefit of ExCR on HRQoL and exercise capacity and support the Class I recommendation of current international clinical guidelines that ExCR should be offered to all HF patients. (Exercise Training for Chronic Heart Failure [ExTraMATCH II]: protocol for an individual participant data meta-analysis; PROSPERO: international database of systematic reviews CRD42014007170).
引用
- Taylor RS, Walker S, Smart NA, et al. Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis. J Am Coll Cardiol. 2019. PMID: 30922474. doi:10.1016/j.jacc.2018.12.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。